{"id":310692,"date":"2019-01-02T07:00:21","date_gmt":"2019-01-02T07:00:21","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=310692"},"modified":"2019-01-02T07:00:21","modified_gmt":"2019-01-02T07:00:21","slug":"amifostine-industry-analysis-global-market-overview-top-companies-growth-factors-and-forecast-2019-to-2024","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/amifostine-industry-analysis-global-market-overview-top-companies-growth-factors-and-forecast-2019-to-2024_310692.html","title":{"rendered":"Amifostine Industry Analysis, Global Market Overview, Top Companies, Growth Factors and Forecast 2019 To 2024"},"content":{"rendered":"
\n
“Amifostine Market”<\/div>\n<\/div>\n
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol<\/div>\n

Summary<\/strong><\/p>\n

WiseGuyReports.com adds “Amifostine Market 2019 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2024”<\/strong> reports to its database.<\/p>\n

This report provides in depth study of “Amifostine Market<\/strong>” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Amifostine <\/strong>Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization.<\/p>\n

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol.<\/p>\n

Global Amifostine<\/strong><\/a> market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
<\/strong>Clinigen Group
Sun Pharmaceutical
Taj Pharmaceuticals
Merro Pharmaceutical
Luye Pharma
Mingren Pharma<\/strong><\/p>\n

Request a Sample Report @ <\/strong>https:\/\/www.wiseguyreports.com\/sample-request\/2928034-2015-2023-world-amifostine-market-research-report-by-product-type<\/strong><\/a><\/p>\n

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.
Market Segment as follows:
By Region \/ Countries
<\/strong>North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc)
South America (Brazil, Argentina etc)
Middle East & Africa (Saudi Arabia, South Africa etc)<\/p>\n

By Type
<\/strong>400mg\/Dose
500mg\/Dose<\/p>\n

By End-User \/ Application
<\/strong>Ovarian Cancer Adjuvant Therapy
Head and Neck Cancer Adjuvant Therapy
Others<\/p>\n

At any Query @ <\/strong>https:\/\/www.wiseguyreports.com\/enquiry\/2928034-2015-2023-world-amifostine-market-research-report-by-product-type<\/strong><\/a><\/p>\n

Major Key Points in Table of Content<\/strong><\/p>\n

1 Market Definition
<\/strong>1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use \/ Application<\/p>\n

2 Global Market by Vendors
<\/strong>2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors<\/p>\n

3 Global Market by Type
<\/strong>3.1 Market Share
3.2 Introduction of End-Use by Different Products<\/p>\n

4 Global Market by End-Use \/ Application
<\/strong>4.1 Market Share
4.2 Overview of Consumption Characteristics
4.2.1 Preference Driven
4.2.2 Substitutability
4.2.3 Influence by Strategy
4.2.4 Professional Needs<\/p>\n

5 Global Market by Regions
<\/strong>5.1 Market Share
5.2 Regional Market Growth
5.2.1 North America
5.2.2 Europe
5.2.3 Asia-Pacific
5.2.4 South America
5.2.5 Middle East & Africa<\/p>\n

…..<\/strong><\/p>\n

12 Key Manufacturers
12.1 Clinigen Group
<\/strong>12.1.2 Company Overview
12.1.2 Product and End-User \/ Application
12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Sun Pharmaceutical
<\/strong>12.2.1 Company Overview
12.2.2 Product and End-User \/ Application
12.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.3 Taj Pharmaceuticals
<\/strong>12.3.1 Company Overview
12.3.2 Product and End-User \/ Application
12.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.4 Merro Pharmaceutical
<\/strong>12.4.1 Company Overview
12.4.2 Product and End-User \/ Application
12.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.5 Luye Pharma
<\/strong>12.5.1 Company Overview
12.5.2 Product and End-User \/ Application
12.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.6 Mingren Pharma
<\/strong>12.12.1 Company Overview
12.12.2 Product and End-User \/ Application
12.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin) <\/strong><\/p>\n

Buy NOW @ <\/strong>https:\/\/www.wiseguyreports.com\/checkout?currency=one_user-USD&report_id=2928034<\/strong><\/a><\/p>\n

Continued….<\/strong><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Wiseguyreports.com
Contact Person:<\/strong> Norah Trent
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> +1 646 845 9349, +44 208 133 9349
City:<\/strong> Pune
State:<\/strong> Maharashtra
Country:<\/strong> India
Website:<\/strong> www.wiseguyreports.comhttps:\/\/www.wiseguyreports.com\/sample-request\/2928034-2015-2023-world-amifostine-market-research-report-by-product-type<\/a><\/p>\n

<\/object><\/p>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

“Amifostine Market” Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol Summary WiseGuyReports.com adds “Amifostine Market 2019 Global Analysis, Growth, Trends and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-310692","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/310692","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=310692"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/310692\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=310692"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=310692"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=310692"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}